CBV-P 70% 1.0ml

新時代　
最高級なリラクゼーションをご体験下さい


※ヴェポライザーは別売りとなっております。

原材料
CBD/CBN/CBD/CBN/THV-c
フレーバー
OG

♯作業中や運転などのご使用はお控えください。 
 
♯お酒を飲んでのご使用はお控えください。未成年の方や妊娠中の方はご使用はお控えください。 
 
※写真に写ってるカートリッジが変更になる時があります 
 
CBDアイソレート CBDワックス CBD CBDハーブ カンナビジオール Vape ヴェポライザー アトマイザー CBC 510スレッド 510規格 CBN CBG CBGリキッド CBNリキッド CBNハーブ CBGハーブ CBNリキッド
商品の情報
カテゴリー
メンズ > 小物 > タバコグッズ
商品の状態
新品、未使用
5810円CBV-P 70% 1.0mlメンズ小物A CT perfusion based model predicts outcome in wake-up stroke

定番人気2023 CBV-P 70% 1.0ml yV2Qp-m58350269900 thinfilmtech.net


CBV-P 70% 1.0ml+rubic.us


WO2021026100A1 - Pyridine derivatives as kif18a inhibitors


Layer-Specific fMRI Responses to Excitatory and Inhibitory


Polymers | Free Full-Text | Ultrastructural and Physicochemical


CBV-P 70% 1.0ml+rubic.us


3d Visualizing Molecular Dynamics Simulation of CAS No. 100-51-6


Cannabinoids in neuroinflammatory disorders: Focusing on multiple


Green energy: Hydroprocessing waste polypropylene to produce


2006 PROCEEDINGS - ASNR


Layer-Specific fMRI Responses to Excitatory and Inhibitory


100-51-6|Phenylmethanol| Ambeed


Comparison of stimulus-evoked cerebral hemodynamics in the awake


CBV-P 70% 1.0ml+rubic.us


Use of CRRT-CVVH in a hemato-oncological ICU in patients treated


Tungsten trioxide-modified zeolite-based catalysts in the


A CT perfusion based model predicts outcome in wake-up stroke


Discovery, Radiolabeling, and Evaluation of Subtype-Selective


CAS No. 4137-56-8


Quantification of cerebral arterial blood volume and cerebral


US20190382814A1 - Biosynthesis of cannabinoid prodrugs and their


A review on the recent advances in HPLC, UHPLC and UPLC analyses


Cerebrovascular reactivity and white matter integrity | Neurology


556-82-1|3-Methyl-2-buten-1-ol| Ambeed


Direct Sulfenylation of the Purine C8–H Bond with Thiophenols


Journal of Microbiology and Antimicrobials - assessment of the


100-51-6|Phenylmethanol|98%


CBV-P 70% 1.0ml+rubic.us


A gut-derived metabolite alters brain activity and anxiety


Tungsten trioxide-modified zeolite-based catalysts in the


Striatal and nigral muscarinic type 1 and type 4 receptors


CAS No. 52980-28-6


Discovery, Radiolabeling, and Evaluation of Subtype-Selective


Average CTP measurements of CBF (mL/100 g/min) after SAH in the


Layer-Specific fMRI Responses to Excitatory and Inhibitory


CN114302878A - Tyrosine kinase non-receptor 1(TNK1) inhibitors and


A Chemical Strategy for Intracellular Arming of an Endogenous


A Chemical Strategy for Intracellular Arming of an Endogenous


Tungsten trioxide-modified zeolite-based catalysts in the


Effects of voluntary exercise on structure and function of